Eruptive keratoacanthomas as a complication of fractionated CO2 laser resurfacing and combination therapy with imiquimod and intralesional methotrexate

Dermatol Surg. 2015 Jan;41(1):172-5. doi: 10.1097/DSS.0000000000000250.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Cutaneous
  • Aged
  • Aminoquinolines / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
  • Female
  • Humans
  • Imiquimod
  • Injections, Intralesional
  • Keratoacanthoma / drug therapy*
  • Keratoacanthoma / etiology
  • Lasers, Gas / adverse effects
  • Methotrexate / administration & dosage
  • Rejuvenation
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / etiology

Substances

  • Aminoquinolines
  • Imiquimod
  • Methotrexate